Telemus Capital, LLC Novartis Ag Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Telemus Capital, LLC holds 8,122 shares of NVS stock, worth $798,798. This represents 0.07% of its overall portfolio holdings.

Number of Shares

8,122

Previous 9,809 17.2%

Holding current value

$798,798

Previous $999,000 17.92%

% of portfolio

0.07%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$92.27 - $101.54 $155,659 - $171,297	-1,687 Reduced 17.2%	8,122 $820,000
Q3 2023 Oct 25, 2023	SELL	$94.73 - $105.13 $419,843 - $465,936	-4,432 Reduced 31.12%	9,809 $999,000
Q2 2023 Jul 10, 2023	SELL	$92.52 - $104.91 $70,500 - $79,941	-762 Reduced 5.08%	14,241 $1.44 Million
Q1 2023 Apr 11, 2023	SELL	$80.03 - $92.81 $113,322 - $131,418	-1,416 Reduced 8.62%	15,003 $1.38 Million
Q4 2022 Jan 11, 2023	SELL	$75.55 - $92.52 $52,885 - $64,764	-700 Reduced 4.09%	16,419 $0
Q3 2022 Oct 11, 2022	SELL	$74.61 - $87.26 $28,650 - $33,507	-384 Reduced 2.19%	17,119 $1.3 Million
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $89,699 - $104,437	-1,114 Reduced 5.98%	17,503 $1.48 Million
Q1 2022 Apr 06, 2022	SELL	$80.11 - $90.62 $53,433 - $60,443	-667 Reduced 3.46%	18,617 $1.63 Million
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $511,913 - $566,058	-6,423 Reduced 24.99%	19,284 $1.69 Million
Q3 2021 Oct 27, 2021	BUY	$81.78 - $95.14 $31,485 - $36,628	385 Added 1.52%	25,707 $2.1 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $179,004 - $197,715	-2,100 Reduced 7.66%	25,322 $2.31 Million
Q1 2021 Apr 20, 2021	BUY	$83.5 - $98.47 $66,382 - $78,283	795 Added 2.99%	27,422 $2.39 Million
Q4 2020 Jan 28, 2021	BUY	$78.07 - $94.43 $46,529 - $56,280	596 Added 2.29%	26,627 $2.51 Million
Q3 2020 Nov 02, 2020	BUY	$82.14 - $91.0 $29,898 - $33,124	364 Added 1.42%	26,031 $2.24 Million
Q2 2020 Jul 17, 2020	BUY	$80.93 - $91.1 $1,861 - $2,095	23 Added 0.09%	25,667 $2.23 Million
Q1 2020 Jun 05, 2020	BUY	$70.67 - $99.01 $102,259 - $143,267	1,447 Added 5.98%	25,644 $2.24 Million
Q4 2019 Jan 24, 2020	SELL	$84.35 - $95.37 $1,012 - $1,144	-12 Reduced 0.05%	24,197 $2.29 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $1,368 - $1,508	-16 Reduced 0.07%	24,209 $2.1 Million
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $22,997 - $28,304	-305 Reduced 1.24%	24,225 $2.2 Million
Q1 2019 May 02, 2019	BUY	$75.32 - $86.15 $7,080 - $8,098	94 Added 0.38%	24,530 $2.36 Million
Q4 2018 Feb 06, 2019	BUY	$73.66 - $82.02 $45,742 - $50,934	621 Added 2.61%	24,436 $2.1 Million
Q3 2018 Oct 23, 2018	SELL	$66.94 - $77.43 $64,262 - $74,332	-960 Reduced 3.87%	23,815 $2.05 Million
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $41,672 - $47,097	-642 Reduced 2.53%	24,775 $1.87 Million
Q1 2018 Apr 27, 2018	SELL	$70.39 - $84.15 $85,594 - $102,326	-1,216 Reduced 4.57%	25,417 $2.06 Million
Q4 2017 Feb 02, 2018	BUY	$72.33 - $77.64 $1.51 Million - $1.62 Million	20,849 Added 360.46%	26,633 $2.24 Million
Q3 2017 Nov 03, 2017	SELL	$74.14 - $77.27 $12,233 - $12,749	-165 Reduced 2.77%	5,784 $497,000
Q2 2017 Apr 03, 2018	SELL	N/A	-89 Reduced 1.47%	5,949 $497,000
Q1 2017 Apr 03, 2018	BUY	N/A	6,038	6,038 $448,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Novartis Ag Transaction History